Skip to main content

Advertisement

SpringerLink
Log in

Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer

  • EPIDEMILOGY
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background Invasive lobular breast carcinoma is known for its multicentricity and is associated with a higher incidence of incomplete excision after breast-conserving therapy. The aim of the study was to examine the influence of positive surgical margins on the local recurrence rate in patients diagnosed with invasive lobular cancer and treated with breast-conserving therapy. Methods All 416 women diagnosed with invasive lobular breast cancer and undergoing breast-conserving treatment between 1995 and 2002 were selected from the population-based Eindhoven Cancer Registry. Their medical charts were reviewed and detailed information was collected. Results The risk of margin involvement was 29% after the first operation and 17% when taking into account the final margin status of the patients undergoing re-excision. During follow-up, 18 patients developed a local recurrence. The 5 year actuarial risk of developing a local recurrence was 3.5% (95% confidence interval 2.5–4.5) and the 8 year risk was 6.4% (95% confidence interval 4.7–8.0). There was no influence of positive surgical margins on the risk of local recurrence, neither in the univariate analysis nor after adjustment for age, tumour size, nodal status and adjuvant systemic treatment. Conclusion Patients with invasive lobular cancer, treated with breast-conservation, have a low risk of local recurrence, despite their high risk of having a microscopically incomplete excision of the tumour.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. The World Health Organization Histological Typing of Breast Tumors–Second Edition (1982) The World Organization. Am J Clin Pathol 78(6):806–816

    Google Scholar 

  2. Wellings SR, Jensen HM, Marcum RG (1975) An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55(2):231–273

    PubMed  CAS  Google Scholar 

  3. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC (1975) The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer 36(1):1–85

    Article  PubMed  CAS  Google Scholar 

  4. Martinez V, Azzopardi JG (1979) Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 3(6):467–488

    Article  PubMed  CAS  Google Scholar 

  5. Verkooijen HM, Fioretta G, Vlastos G et al. (2003) Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 104(6):778–81

    Google Scholar 

  6. Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289(11):1421–1424

    Article  PubMed  Google Scholar 

  7. Sastre-Garau X, Jouve M, Asselain B, et al. (1996) Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 77(1):113–120

    Article  PubMed  CAS  Google Scholar 

  8. Yeatman TJ, Cantor AB, Smith TJ et al. (1995) Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222(4):549–559; discussion. 559–561

    Google Scholar 

  9. Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM et al. (1994) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 73(6):1673–1677

    Article  PubMed  CAS  Google Scholar 

  10. Moore MM, Borossa G, Imbrie JZ et al. (2000) Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg 231(6):877–882

    Article  PubMed  CAS  Google Scholar 

  11. Peiro G, Bornstein BA, Connolly JL (2000) The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59(1):49–54

    Article  PubMed  CAS  Google Scholar 

  12. Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR (1997) Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol 4(7):545–550

    Article  PubMed  CAS  Google Scholar 

  13. Singletary SE, Patel-Parekh L, Bland KI (2005) Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann Surg 242(2):281–289

    Article  PubMed  Google Scholar 

  14. Holland PA, Shah A, Howell A, Baildam AD, Bundred NJ (1995) Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg 82(10):1364–1366

    Article  PubMed  CAS  Google Scholar 

  15. Bouvet M, Ollila DW, Hunt KK, Babiera GV et al. (1997) Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol 4(8):650–654

    Article  PubMed  CAS  Google Scholar 

  16. Kurtz JM, Jacquemier J, Torhorst J et al. (1989) Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 63(8):1630–1635

    Article  PubMed  CAS  Google Scholar 

  17. Schnitt SJ, Connolly JL, Recht A, Silver B, Harris JR (1989) Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 64(2):448–454

    Article  PubMed  CAS  Google Scholar 

  18. Poen JC, Tran L, Juillard G et al. (1992) Conservation therapy for invasive lobular carcinoma of the breast. Cancer 69(11):2789–2795

    Article  PubMed  CAS  Google Scholar 

  19. Salvadori B, Biganzoli E, Veronesi P, Saccozzi R, Rilke F (1997) Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg 84(1):106–109

    Article  PubMed  CAS  Google Scholar 

  20. White JR, Gustafson GS, Wimbish K et al. (1994) Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. The role of preoperative mammograms in guiding treatment. Cancer 74(2):640–647

    Article  PubMed  CAS  Google Scholar 

  21. Mai KT, Yazdi HM, Isotalo PA (2000) Resection margin status in lumpectomy specimens of infiltrating lobular carcinoma. Breast Cancer Res Treat 60(1):29–33

    Article  PubMed  CAS  Google Scholar 

  22. Morrow M, Keeney K, Scholtens D, Wei J, Steel J, Khan SA (2006) Selecting patients for breast-conserving therapy: the importance of lobular histology. Cancer 106(12):2563–2568

    Article  PubMed  Google Scholar 

  23. Newman LA, Kuerer HM (2005) Advances in breast conservation therapy. J Clin Oncol 23(8):1685–1697

    Article  PubMed  Google Scholar 

  24. Voogd AC, Nielsen M, Peterse JL et al. (2001) Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol1.9(6):1688–1697

    Google Scholar 

  25. Rutgers EJ, Nortier JW, Tuut MK et al. (2002) [Dutch Institute for Healthcare Improvement guideline, “Treatment of breast cancer”]. Ned Tijdschr Geneeskd 146(45):2144–2151

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Maastricht University, Maastricht, The Netherlands

    N. van den Broek

  2. Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands

    M. J. C. van der Sangen

  3. Eindhoven Cancer Registry, Eindhoven, The Netherlands

    L. V. van de Poll-Franse

  4. Regional Institute of Pathology (PAMM), Eindhoven, The Netherlands

    M. W. P. M. van Beek

  5. Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands

    G. A. P. Nieuwenhuijzen

  6. Department of Epidemiology, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands

    A. C. Voogd

Authors
  1. N. van den Broek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. J. C. van der Sangen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. V. van de Poll-Franse
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. W. P. M. van Beek
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. A. P. Nieuwenhuijzen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. C. Voogd
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. C. Voogd.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van den Broek, N., van der Sangen, M.J.C., van de Poll-Franse, L.V. et al. Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat 105, 63–68 (2007). https://doi.org/10.1007/s10549-006-9431-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-006-9431-5

Keywords

Search

Navigation